Ampio Pharmaceuticals

Update in progress

AMPE (OTC Markets OTCPK)

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for knee osteoarthritis (OAK) in the United States. Its principal program, OA-201, is a small-molecule formulation designed to alleviate pain and improve function in adults with OAK. The company advances research and development from its Englewood, Colorado headquarters, pursuing early- to mid-stage clinical work and potential partnerships to bring new options to patients.